The DR is characterized by damage to the retinal blood vessels, primarily due to chronic hyperglycemia-induced retinal hypoxia, which activates hypoxia-inducible factors that upregulate EPO and vascular endothelial growth factor (VEGF) [22]. The gene discussed is VEGFA; the disease is Hyperglycemia.